J-SAP study 1-2: Outcomes of patients with stable high-risk coronary artery disease receiving medical-preceding therapy in Japan - A comparison with CABG-preceding therapy

Circulation Journal

Volumn 70, Issue 8, 2006, Pages 1012-1016

  Fukunishi, Masanori ^a   Nishigaki, Kazuhiko ^a   Okubo, Munenori ^a   Kawasaki, Masanori ^a   Takemura, Genzou ^a   Minatoguchi, Shinya ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Coronary artery bypass grafting; High risk coronary artery disease; Medical preceding therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HEART DEATH; HUMAN; INCIDENCE; JAPAN; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PROGNOSIS; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RANDOM ALLOCATION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 33746712898     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1012     Document Type: Article

References (9)

1. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). Circulation 1999; 99: 2829-2848.
2. CASS principal investigators and their associates. Coronary artery surgery study (CASS): A randomized trial of coronary artery bypass surgery: Survival data. Circulation 1983; 68: 939-950.
3. Varnauskas E. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery. Circulation 1985; 72: V90-V101.
4. Detre KM, Takaro T, Hultgren H, Peduzzi P. Long-term mortality and morbidity results of the Veterans Administration randomized trial of coronary artery bypass surgery. Circulation 1985; 72: V84-V89.
5. Tanihata S, Nishigaki K, Kawasaki M, Takemura G, Minatoguchi S, Fujiwara H. Outcomes of patients with stable low-risk coronary artery disease receiving medical- and PCI-preceding therapies in Japan: J-SAP Study 1-1. Circ J 2006; 70: 365-369.
6. Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: A meta-analysis. Circulation 2005; 111: 2906-2912.
7. Nishigaki K, Yamazaki T, Fujiwara H. Assessment of Coronary Intervention in Japan from the Japanese Coronary Intervention Study (JCIS) Group: Comparison between 1997 and 2000. Circ J 2004; 68: 181-185.
8. Nishida H, Tomizawa Y, Endo M, Kurosawa H. Survival benefit of exclusive use of in situ arterial conduits over combined use of arterial and vein grafts for multiple coronary artery bypass grafting. Circulation 2005; 112(Suppl I): I-299-I-303.
9. Legare JF, Buth KJ, Sullivan JA, Hirsch GM. Composite arterial grafts versus conventional grafting for coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004; 127: 160-166.